Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.
Applied during hemodialysis, the effect rate were 8.3%, 71.4%, 68.2% respectively in midodrine hydrochloride tablet group compound amino acid group, 50% glucose group.